Onxeo attends InvestorDagen 2014, the largest Danish private investor event
Onxeo SA (Euronext Paris, NASDAQ OMX Copenhagen - ONXEO), an innovative company specialized in the development of drugs for orphan oncology diseases, attended InvestorDagen 2014, held in Copenhagen on September 17, 2014.
InvestorDagen is hosted by the Danish Shareholders’ Association, an association with 12,000 members. With around 2,500 participants, InvestorDagen is the largest event for private investors in Denmark.
For its first participation, Onxeo’s management team gave a presentation of the Company, its key strengths, its strategy based on advanced orphan oncology products and the mid-term news flow which is expected to drive value and future growth. This event was also the opportunity to meet and exchange with the participating Danish investors who were many to visit Onxeo’s booth, making a great success of this meeting.